P3 or not P310 Feb 2022 17:56
Reading between the lines, Synairgen will post P3 results before or on the 28th February. After the Director/PDMR declaration it was never going to be before 14th Feb as to close for comfort.
The EU roles via Ashfield also indicate that Synairgen will be pushing for Emergency use in Europe as well as the USA, which greatly expands their market.
With the UK looking to drop testing and just get on with covid, it is highly likely that they will also buy SNG001 as this will mitigate deaths.
Polygon have a significant holding in Synairgen and the takeover code discusses both 10% and 30% shareholdings as follows;
When a person or group acquires interests in shares carrying 30% or more of the voting rights of a company, they must make a cash offer to all other shareholders at the highest price paid in the 12 months before the offer was announced (30% of the voting rights of a company is treated by the Code as the level at which effective control is obtained).
When interests in shares carrying 10% or more of the voting rights of a class have been acquired by an offeror (i.e. a bidder) in the offer period and the previous 12 months, the offer must include a cash alternative for all shareholders of that class at the highest price paid by the offeror in that period. Further, if an offeror acquires for cash any interest in shares during the offer period, a cash alternative must be made available at that price at least.
Hold onto your shares and lets hope there is no offer from Polygon before we get the P3 results!
Sign In
Follow the stocks
